MedPath

Indocyanine green acid form

Generic Name
Indocyanine green acid form
Brand Names
Ic-green
Drug Type
Small Molecule
Chemical Formula
C43H48N2O6S2
CAS Number
28782-33-4
Unique Ingredient Identifier
C4V974V932
Background

Indocyanine Green is a water soluble, tricarbocyanine dye with a peak spectral absorption at 800 nm. The chemical name for Indocyanine Green is 1 H-Benz[e]indolium, 2-[7-[1,3-dihydro-1,1-dimethyl-3-(4-sulfobutyl)-2H-benz[e] indol-2-ylidene]-1,3,5-heptatrienyl]-1,1-dimethyl-3-(4-sulfobutyl)-,hydroxide, inner salt, sodium salt. Indocyanine Green for Injection USP has a pH of approximately 6.5 when reconstituted. Each vial of Indocyanine Green for Injection USP contains 25 mg of Indocyanine Green as a sterile lyophilized powder with no more than 5% sodium iodide.

Indication

For Determining Cardiac Output, Hepatic Function and Liver Blood Flow

For ophthalmic angiography

NIR Fluorescence Imaging of Lymphatic Transport Using ICG

Phase 1
Completed
Conditions
Rheumatoid Arthritis
Interventions
Device: MultiSpectral Imaging System
First Posted Date
2016-02-11
Last Posted Date
2022-10-18
Lead Sponsor
University of Rochester
Target Recruit Count
23
Registration Number
NCT02680067
Locations
🇺🇸

University of Rochester, Rochester, New York, United States

The Impact of Indocyanine Green-enhanced Fluorescence Imaging on Bowel Transection in Left-sided Colorectal Resection

Not Applicable
Conditions
Anastomotic Leak
Interventions
Device: Fluorescence imaging
First Posted Date
2016-02-01
Last Posted Date
2016-02-01
Lead Sponsor
The University of Hong Kong
Target Recruit Count
30
Registration Number
NCT02669485
Locations
🇭🇰

Queen Mary Hospital, Hong Kong, Hong Kong

Minimally Invasive Imagery With Indocyanine Green

Phase 1
Completed
Conditions
Neoplasms
Interventions
First Posted Date
2015-12-03
Last Posted Date
2018-03-20
Lead Sponsor
University of Pennsylvania
Target Recruit Count
48
Registration Number
NCT02621268
Locations
🇺🇸

Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

NIR Fluorescence Imaging Technique in Thoracic Surgery With ICG

Phase 1
Completed
Conditions
Lung Cancer
Esophageal Cancer
Interventions
First Posted Date
2015-11-20
Last Posted Date
2018-06-08
Lead Sponsor
Chinese Academy of Sciences
Target Recruit Count
36
Registration Number
NCT02611245
Locations
🇨🇳

Key Laboratory of Molecular Imaging, Chinese Academy of Sciences, Beijing, Beijing, China

Near-Infrared Fluorescence Guided Robotic Pulmonary Segmentectomy for Early Stage Lung Cancer

Phase 1
Recruiting
Conditions
Non-small Cell Lung Cancer
Interventions
First Posted Date
2015-10-07
Last Posted Date
2024-12-06
Lead Sponsor
St. Joseph's Healthcare Hamilton
Target Recruit Count
250
Registration Number
NCT02570815
Locations
🇨🇦

St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada

ENB Robotic ICG Guided Surgery: A Novel Technique for Targeting Small Lung Tumors

Phase 1
Withdrawn
Conditions
Non-small Cell Lung Cancer
Thoracic Surgery
Interventions
First Posted Date
2015-10-07
Last Posted Date
2017-06-05
Lead Sponsor
St. Joseph's Healthcare Hamilton
Registration Number
NCT02570958

Clinical Application of Dual Sentinel Lymph Node Staining Method in Breast Cancer Patients

Phase 2
Completed
Conditions
Breast Cancer
Interventions
Drug: Radioisotope
First Posted Date
2015-06-24
Last Posted Date
2023-02-22
Lead Sponsor
National Cancer Center, Korea
Target Recruit Count
130
Registration Number
NCT02479997
Locations
🇰🇷

National Cancer Center, Goyang-si, Gyeonggi-do, Korea, Republic of

Clinical Application of Near-infrared Fluorescence Guided Localization on Breast Surgery in Breast Cancer

Phase 2
Conditions
Breast Cancer
Interventions
First Posted Date
2015-06-16
Last Posted Date
2015-06-18
Lead Sponsor
National Cancer Center, Korea
Target Recruit Count
5
Registration Number
NCT02473159
Locations
🇰🇷

National Cancer Center, Goyang-si, Gyeonggi-do, Korea, Republic of

Comparison of Use of Indocyanine Green and 99mTc-labeled Radiotracer for Axillary Lymphatic Mapping in Patients With Breast Cancer

Not Applicable
Completed
Conditions
Stage I Breast Cancer
Stage II Breast Cancer
Interventions
Radiation: Technetium Tc-99m Sulfur Colloid
Procedure: Lymphoscintigraphy
Procedure: Axillary Lymph Node Biopsy
First Posted Date
2015-04-17
Last Posted Date
2022-06-30
Lead Sponsor
Case Comprehensive Cancer Center
Target Recruit Count
102
Registration Number
NCT02419807
Locations
🇺🇸

Cleveland Clinic Taussig Cancer Instititute, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Early Detection of Lymphedema After Cancer Treatments

Not Applicable
Conditions
Lymphadenectomy
Breast Cancer
Interventions
First Posted Date
2015-04-14
Last Posted Date
2015-04-14
Lead Sponsor
Centre Hospitalier Universitaire Saint Pierre
Target Recruit Count
120
Registration Number
NCT02415725
Locations
🇧🇪

CHU St-Pierre - Clinique de Lymphologie, Brussels, Belgium

© Copyright 2025. All Rights Reserved by MedPath